We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

On Monday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $129.43 which represents a slight increase of $4.40 or 3.52% from the prior close of $125.03. The stock opened at $ ...

The company’s projected adjusted diluted EPS for 2025 is between $5.05 and $5.25, marking double-digit growth at the midpoint. Abbott’s first-quarter 2025 adjusted EPS is expected to be between $1.05 ...

With a trading volume of 5,249,687, the price of ABT is down by -0.19%, reaching $122.98. Current RSI values indicate that ...

Arcblock (ABT) shot up by more than 45% in the past 24 hours and claimed a daily high of $1.92, facing resistance at $2.

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

We recently published a list of 10 Stocks Expected To Post Impressive Earnings This Week. In this article, we are going to ...

The theater is one of the biggest and best classrooms in the state, and has been offering matinees to hundreds of students at a time for over 30 years now.

In a report released on January 17, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Abbott Laboratories (ABT – Research ...